Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 12 | $1,101,854 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 Jan 2025 12:10 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 29 Jan 2025 | Sale | 278 | 29.5236 | 8,208 | D |
| 23 Jan 2025 15:26 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 22 Jan 2025 | Sale | 1,291 | 30.4255 | 39,279 | D |
| 14 Jan 2025 16:15 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 13 Jan 2025 | Sale | 264 | 28.7021 | 7,577 | D |
| 27 Dec 2024 16:06 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 23 Dec 2024 | Sale | 63 | 33.09 | 2,085 | D |
| 31 Jan 2024 16:23 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 29 Jan 2024 | Sale | 279 | 64.1382 | 17,895 | D |
| 31 Jan 2024 16:23 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 30 Jan 2024 | Sale | 971 | 65.53 | 63,630 | D |
| 24 Jan 2024 16:03 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 23 Jan 2024 | Sale | 7,378 | 63.69 | 469,905 | D |
| 23 Jan 2024 18:05 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 22 Jan 2024 | Sale | 1,607 | 64.996 | 104,449 | D |
| 18 Jan 2024 16:55 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 17 Jan 2024 | Sale | 5,207 | 65.58 | 341,475 | D |
| 17 Jan 2024 12:24 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 16 Jan 2024 | Sale | 438 | 66.8086 | 29,262 | D |
| 28 Dec 2023 16:13 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 27 Dec 2023 | Sale | 235 | 60.23 | 14,154 | D |
| 28 Dec 2023 16:13 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 26 Dec 2023 | Sale | 68 | 57.8609 | 3,935 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)